中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
4期
277-281
,共5页
丁毅鹏%姚红霞%何海武%石慧芳%林莉
丁毅鵬%姚紅霞%何海武%石慧芳%林莉
정의붕%요홍하%하해무%석혜방%림리
受体,血栓烷A2,前列腺素H2%肺动脉%肌细胞,平滑肌%细胞增殖%细胞凋亡
受體,血栓烷A2,前列腺素H2%肺動脈%肌細胞,平滑肌%細胞增殖%細胞凋亡
수체,혈전완A2,전렬선소H2%폐동맥%기세포,평활기%세포증식%세포조망
Receptors,thromboxane A2,Prostaglandin H2%Pulmonary artery%Myocytes,smooth muscle%Cell proliferation%Apoptosis
目的 探讨血栓素A2(TXA2)合成酶抑制剂奥扎格雷钠对低氧肺动脉平滑肌细胞(PASMC)增殖及凋亡的影响.方法 采用四甲基偶氮唑盐微量比色法、免疫组化法及原位末端脱氧核苷酸转移酶标记法观察TXA2激动剂U46619及TXA2合成酶抑制剂奥扎格雷钠对PASMC增殖及凋亡和对反映细胞增殖状态的重要标记物Ki67表达的影响.结果 U46619对常氧和低氧PASMC的增殖和低氧PASMC中Ki67的表达均有明显促进作用,并可明显抑制PASMC的凋亡;奥扎格雷钠对常氧PASMC的增殖无明显影响,但对低氧PASMC的增殖和Ki67的表达均有明显抑制作用,可促进低氧PASMC的凋亡;奥扎格雷钠可明显拮抗U46619在常氧和低氧条件下对PASMC的促增殖和Ki67表达的作用,以及U46619抑制低氧PASMC的凋亡的作用.结论 奥扎格雷钠有可能通过抑制低氧PASMC的增殖及血管重塑、促进凋亡,从而对低氧性肺动脉高压起治疗作用.
目的 探討血栓素A2(TXA2)閤成酶抑製劑奧扎格雷鈉對低氧肺動脈平滑肌細胞(PASMC)增殖及凋亡的影響.方法 採用四甲基偶氮唑鹽微量比色法、免疫組化法及原位末耑脫氧覈苷痠轉移酶標記法觀察TXA2激動劑U46619及TXA2閤成酶抑製劑奧扎格雷鈉對PASMC增殖及凋亡和對反映細胞增殖狀態的重要標記物Ki67錶達的影響.結果 U46619對常氧和低氧PASMC的增殖和低氧PASMC中Ki67的錶達均有明顯促進作用,併可明顯抑製PASMC的凋亡;奧扎格雷鈉對常氧PASMC的增殖無明顯影響,但對低氧PASMC的增殖和Ki67的錶達均有明顯抑製作用,可促進低氧PASMC的凋亡;奧扎格雷鈉可明顯拮抗U46619在常氧和低氧條件下對PASMC的促增殖和Ki67錶達的作用,以及U46619抑製低氧PASMC的凋亡的作用.結論 奧扎格雷鈉有可能通過抑製低氧PASMC的增殖及血管重塑、促進凋亡,從而對低氧性肺動脈高壓起治療作用.
목적 탐토혈전소A2(TXA2)합성매억제제오찰격뢰납대저양폐동맥평활기세포(PASMC)증식급조망적영향.방법 채용사갑기우담서염미량비색법、면역조화법급원위말단탈양핵감산전이매표기법관찰TXA2격동제U46619급TXA2합성매억제제오찰격뢰납대PASMC증식급조망화대반영세포증식상태적중요표기물Ki67표체적영향.결과 U46619대상양화저양PASMC적증식화저양PASMC중Ki67적표체균유명현촉진작용,병가명현억제PASMC적조망;오찰격뢰납대상양PASMC적증식무명현영향,단대저양PASMC적증식화Ki67적표체균유명현억제작용,가촉진저양PASMC적조망;오찰격뢰납가명현길항U46619재상양화저양조건하대PASMC적촉증식화Ki67표체적작용,이급U46619억제저양PASMC적조망적작용.결론 오찰격뢰납유가능통과억제저양PASMC적증식급혈관중소、촉진조망,종이대저양성폐동맥고압기치료작용.
Objective To study the effect of Thromboxane A2 (TXA2) inhibitor on the proliferation of hypoxic pulmonary artery smooth muscle cells (PASMC) of porcines. Methods The methods of 3(4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide ( MTT), immunohistochemistry of Ki67 and TdTmediated dUTP nick end labeling(TUNEL) were employed to measure the proliferation, inhibition rate and apoptosis of PASMC. Results U46619, a thromboxane A2 agonist, could promote the proliferation and expression of Ki67 in PASMC under hypoxic and normal conditions. It could also inhibit the apoptosis of PASMC. Ozagrel, a thromboxane A2 inhibiter, inhibited the proliferation and the expression of Ki67 in PASMC under hypoxia. The inhibition rate was 71.4%, but it had no effect on the proliferation and expression of Ki67 in PASMC under normal conditions. It promoted the apoptosis of PASMC. Ozagrel could inhibit the action of U46619 in promoting the proliferation and expression of Ki67 in PASMC and inhibit the apoptosis of PASMC. Conclusion Ozagrel may be used in treating the pulmonary hypertension by inhibiting the proliferation of PASMC, pulmonary vascular remodeling, and promote the apoptosis of PASMC.